drugset / Trial / NCT00987103

Pharmacokinetic Study to Rectal and Sublingual Administration of Tacrolimus in Future Kidney Transplant Patients

NCT00987103

Phase 1 Unknown 18 enrolled Maastricht University Medical Center
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to investigate the pharmacokinetics of rectal and sublingual administration of tacrolimus and to compare with pharmacokinetics after oral administration of tacrolimus in renal transplant patients before transplantation.

Timeline

Start
2009-09
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule 0.04 mg/kg Oral
Subject Tacrolimus Small molecule 0.1 mg/kg Oral
Subject Tacrolimus Small molecule 15 mg Oral